Name: Allyssa Venus W.
Ferrer Date: June 08, 2021
Generic Name: Ketorolac
Brand Name: Toradol
Dose/ Route/Frequency: 1 amp IV 8h
Mechanism of action: Interferes with
prostaglandin biosynthesis by inhibiting
cyclooxygenase pathway of arachidonic
acid metabolism; also acts as potent
inhibitor of platelet aggregations
Classification: Nonsteroidal anti-
inflammatory agent, Nonopioid
analgesics
Nursing Responsibilities
Action
1. Monitor for adverse reactions such as Fever, blisters,
unexplained weight gain, shortness of breath or difficulty
breathing, swelling in the abdomen, ankles, feet, or legs,
yellowing of the skin or eyes, excessive tiredness, unusual
bleeding or bruising, lack of energy, nausea, loss of appetite,
pain in the upper right part of the stomach, flu-like symptoms,
pale skin, fast heartbeat, cloudy, discolored, or bloody urine,
back pain, difficult or painful urination, especially prolonged
bleeding time and CNS reactions.
2. Monitor fluid intake and output.
3. Inform patient that drug is meant only for short-term pain
management.
4. Advise patient by eating small, frequent servings of healthy foods.
5. Instruct patient to avoid aspirin products and herbs during therapy.
6. Advise patient to avoid driving and other hazardous activities.
7. Drug is indicated for short-term management (up to 5 days in
adults) of moderately severe acute pain that requires opioid-level
analgesia. It’s not indicated for minor or chronic painful conditions.
Rationale
Drug may casue  inhibitor of platelet aggregation with a
theoretical increased bleeding risk
Drug may cause kidney failure
The drug may cause
To minimize GI upset
Combining these medications may increase the risk of
side effects in the gastrointestinal tract such as
inflammation, bleeding, ulceration, and rarely,
perforation.
drug affects concentration and alertness.
Drug carries many risks; NSAID-related adverse events
can be serious in certain patients, especially when used
inappropriately. Raising dosage beyond
recommendations increases risk of serious adverse events
|1

8. Contraindicated in patients with active peptic ulcer disease, recent
GI bleeding or perforation, or history of peptic ulcer disease or GI
bleeding.
9. Drug is contraindicated in advanced renal impairment and patients
at risk for renal failure.
10. Contraindicated in patients with suspected or confirmed
cerebrovascular bleeding, hemorrhagic diathesis, incomplete
hemostasis, or high risk of bleeding.
11. Hypersensitivity reactions ranging from bronchospasm to
anaphylactic shock have occurred. Ensure that appropriate
counteractive measures are available when giving first dose of
injection form.
12. Drug is contraindicated for intrathecal or epidural
administration, during labor and delivery, in breastfeeding women,
and in patients currently receiving aspirin or NSAIDs
*side/adverse effect must be incorporated in the nursing intervention
and won’t provide better efficacy.
Drug can cause peptic ulcers, GI bleeding, and
perforation
Drug may cause kidney failure
Drug inhibits platelet function
Drug is contraindicated in known hypersensitivity to
ketorolac or allergic reaction to aspirin or other NSAID.
intrathecal or epidural administration due to alcohol
content, during labor and delivery may impede fetal
circulation and inhibit uterine contractions, in
breastfeeding women due to potential adverse effects of
prostaglandin inhibiting drugs on neonates, and in
patients currently receiving aspirin or NSAIDs due to
cumulative risk of serious NSAID-related adverse effects.
|2
Name: Allyssa Venus W. Ferrer Date: June 08, 2021
Generic Name: Silver sulfadiazine
Brand Name: Silvadene
Dose/ Route/Frequency: topical BID
Mechanism of action: works by stopping the growth of
bacteria that may infect an open wound. This helps to
decrease the risk of the bacteria spreading to surrounding
skin, or to the blood where it can cause a serious blood
infection (sepsis)
Classification: Anti-microbial, sulfa antibiotics
Nursing Responsibilities
Action Rationale
1. Use with open treatment or with light or to help reduce pain, promote healing, and prevent wound
occlusive dressing desiccation and can provide faster healing
2. Wear sterile gloves when apply this to keep the treatment area as clean as possible to prevent
medicine. Apply a thin layer (about 1/16 inch) further infection.
of silver sulfadiazine to the affected areas.
Keep the affected areas covered with the
medicine at all times.
3. Use after through wound cleansing and remove For faster absorption
dead or burned skin and other debris.
4. After this medicine has been applied, the to reduce the risk of infection.
treated areas may be covered with a
dressing or left uncovered as desired.
5. Use caution in G6PD deficiency hemolysis may occur
6. Assess if allergic to it; or to other sulfa The product may contain inactive ingredients, which can
antibiotics (such as sulfamethoxazole); or if cause allergic reactions or other problems.
you have any other allergies.
7. Tell the physician if any of this drug is being products that may interact with the drug
used cimetidine, skin products containing
sodium sulfacetamide, enzyme products used
to break down and remove dead skin/tissue
from burns and wounds (such as collagenase,
papain, trypsin)
|3
 8. Check for blood dyscrasias, dermatologic and possible adverse reaction associated with sulfonamides
allergic reactions (including life-threatening
cutaneous reactions [Stevens-Johnson
syndrome (SJS), toxic epidermal necrolysis
(TEN), exfoliative dermatitis]), GI reactions,
hepatitis and hepatocellular necrosis, CNS
reactions, and toxic nephrosis
9. Use with caution to Kidney disease or The effects may be increased because of slower removal
Liver disease of the medicine from the body

10. Store the medicine in a closed container at To avoid drug

room temperature, away from heat,
moisture, and direct light. Keep from
freezing.
11. Check for bleeding gums, cough or These could be symptoms of a blood disorder.
hoarseness, fever with or without chills,
painful or difficult urination, sores, ulcers,
or white spots on the lips or in the mouth,
unusual bleeding, bruising, or weakness, or
yellow skin or eyes.
*side/adverse effect must be incorporated in the nursing intervention

|4